Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

INTRODUCTION: Malignant pleural mesothelioma (MPM) is an incurable malignant disease, which results from chronic exposition to asbestos in at least 70% of the cases. Fibroblast activation protein (FAP) is predominantly expressed on the surface of reactive tumor-associated fibroblasts as well as on p...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuberth, Petra C, Hagedorn, Christian, Jensen, Shawn M, Gulati, Pratiksha, van den Broek, Maries, Mischo, Axel, Soltermann, Alex, Jüngel, Astrid, Marroquin Belaunzaran, Osiris, Stahel, Rolf, Renner, Christoph, Petrausch, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751305/
https://www.ncbi.nlm.nih.gov/pubmed/23937772
http://dx.doi.org/10.1186/1479-5876-11-187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751305/
https://www.ncbi.nlm.nih.gov/pubmed/23937772
http://dx.doi.org/10.1186/1479-5876-11-187

Ejemplares similares